01.03.2026, 1386 Zeichen
KTM: Bajaj Mobility AG announced that its subsidiary KTM AG has successfully secured a loan to refinance its existing debt with Bajaj Auto International Holdings B.V. As part of last year’s restructuring, Bajaj Auto International Holdings B.V. provided KTM AG with a loan of EUR 450 million in May 2025 to finance the restructuring plan quota. The current refinancing loan agreement is granted by an international banking consortium and has a total volume of EUR 550 million. The loan is unsecured, has a 5-year term, and bears interest in the low to mid-single-digit percentage range. During the term of the loan agreement, KTM AG is subject to market-standard restrictions on dividend distributions.
Bajaj Mobility AG: weekly performance:
FACC: Aerospace supplier FACC has been selected by Embraer to develop and manufacture new interior components for the new Praetor 600E and 500E. FACC develops an intelligent and optimized cabin design that creates a completely new sense of space. Modern lightweight technology from FACC combined with surfaces made of high-quality processed leather, elegant wood veneers, and refined metals create an atmosphere of absolute well-being – including in-flight entertainment that is seamlessly integrated into the sidewall.
FACC: weekly performance:
(From the 21st Austria weekly https://www.boerse-social.com/21staustria (27/02/2026)
Börsepeople im Podcast S24/26: Birgit Noggler
1.
FACC entwickelt und fertigt neue Kabinen-Komponenten für Embraer Business Jets Praetor 600E und Praetor 500E; Fotoquelle: FACC
, (© Aussender) >> Öffnen auf photaq.com
Aktien auf dem Radar:Frequentis, Agrana, Telekom Austria, Amag, UBM, Austriacard Holdings AG, Andritz, Wienerberger, Zumtobel, Porr, Marinomed Biotech, Addiko Bank, AT&S, Erste Group, Palfinger, Rath AG, Wolftank-Adisa, Polytec Group, BKS Bank Stamm, Oberbank AG Stamm, Mayr-Melnhof, EuroTeleSites AG, CPI Europe AG, Österreichische Post, Semperit, Infineon, Münchener Rück, Zalando, Siemens Energy, Merck KGaA, Fresenius Medical Care.
Marinomed
Marinomed hat die Vision, das Leben von Patienten, die an Krankheiten mit unzureichenden Behandlungsmöglichkeiten leiden, in zwei wichtigen therapeutischen Bereichen nachhaltig zu verbessern: Virologie und Immunologie.
>> Besuchen Sie 55 weitere Partner auf boerse-social.com/partner